PRIME Journal is part of the Informa Markets Division of Informa PLC

Informa PLC
About us
Investor relations
Talent

PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Injectables
Dermatology
Anti-ageing
Body Contouring
Invasive treatments

Home
Aesthetic features
News
Industry Insider
Practice Management
Case Study
Events
Digital Magazine
Register

Select Page

Revolutionary brand-new technology is offering a very real solution for cellulite

Mar 14, 2018 | News | 0 |

Aesthetic device manufacturer BTL Aesthetics has unveiled its latest innovation as it adds yet another new product to its expansive treatment

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User RegistrationFirst Name*

Last Name*

Job Title*

Email*

Choose a Username*

Do you wish to receive FREE digital copies of PRIME and Subscribe to PRIME Newsletter?*

Yes
No

Do you wish to receive printed copies of PRIME? (€180 per annum)*

Yes
No

Would you like to join the Aesthetic Multispecialty Society? Find out more here: https://multispecialtysociety.com/*

Yes contact me for a basic membership
Yes contact me for a Premium membership
No thank you

Would you like to receive occasional offers from other select Informa Group and third parties?*

Yes
No

Address 1*

Address 2

City*

State*

Zip*

Country*

Password*

Confirm Password*

Please indicate that you agree to the Terms of Service *

*Required field

Share:

Rate:

PreviousAptos Master Class launched at new training centre in Tbilisi, Georgia

NextSculpSure Submental launches in the UK

Related Posts

Scientists wage fight against aging bone marrow stem cell niche

March 13, 2017

Award-winning iConsult system launches new branding & website

January 17, 2017

Response to the new Government legislation to name and shame substandard cosmetic surgery clinics

August 23, 2016

Allergan receives FDA approval to market JUVEDERM ULTRA XC for lip augmentation

October 5, 2015

Search

Search for:

Recent Posts

Harpar Grace announce the launch of the iS Clinical World Star Contest 2021
Award-winning, Swiss skincare line – MEDER BEAUTY Partners with GetHarley
AMWC Monaco is back this September
HARPAR GRACE RELEASE DATE FOR NEW iS CLINICAL ADVANCED VIRTUAL SEMINAR
New Study Confirms Physicians Perform the Majority of Cosmetic Injections

Login Status

Username or Email

Password

Forgot? Register

Upcoming Events

AMWC 2021 – The Hybrid Edition

Start date: September 16, 2021 - End date: September 18, 2021

Location: Monte Carlo, Monaco and Online

AMWC LATIN AMERICA 2021

Start date: October 21, 2021 - End date: October 23, 2021

Location: Medellin, Colombia

AMWC China 2021

Start date: October 22, 2021 - End date: October 24, 2021

Location: Chengdu, China

Recent Tweets

Skin Pigmentation Mechanism Confers Major Protection Against UV-Related Cancers lnkd.in/gySCrsUc #skin �twitter.com/i/web/status/1…QXB
4 weeks ago • Reply • Retweet • Favorite
Come and join us this September in Monaco. lnkd.in/gjN9Sx2 #primejournal #mediapartner #amwcconference�twitter.com/i/web/status/1…IS
1 month ago • Reply • Retweet • Favorite
Research reveals clues to how a molecule improves appearance of surgery scars lnkd.in/gPvrkBtx #scars �twitter.com/i/web/status/1…SJ6
1 month ago • Reply • Retweet • Favorite
The June/July 2021 is out! lnkd.in/ebmjKuq #NAD+ #face #neck #periorbital #blepharoplasty #eyelidlift�twitter.com/i/web/status/1…5M
3 months ago • Reply • Retweet • Favorite
DOCTORS WARN AGAINST DO-IT-YOURSELF INJECTIONS TRENDING DURING PANDEMIC lnkd.in/gUwMVYU #warning�twitter.com/i/web/status/1…jI
3 months ago • Reply • Retweet • Favorite

Follow @PrimeJournal

Categories

Injectables
Dermatology
Anti-ageing
Body Contouring
Invasive treatments
Case Study
Practice Management
Sponsored
Industry Insider
Company Profile
PRIME People
Meeting reviews
Commentary

Copyright © 2021. All rights reserved. Informa Markets, a trading division of Informa PLC.

Accessibility
Privacy Policy
Cookie Policy
Terms of use
Visitor Terms and Conditions Link